AGEN (Agenus, Inc.) Sof foyda

AGEN (Agenus Inc.) - kompaniyaning tovar belgisi

Agenus (AGEN) kompaniyasi eski ishlanmalarga bo'lgan huquqlarni sanoatning yirik ishtirokchilariga sotish orqali faqat onkologiyaga yo'naltirilgan bog'liqligini kamaytirishga intilmoqda. Tibbiyot markazlariga muhim ta'minotlarni yetkazib berish samaradorligi optimallashtirilgan global ta'minot zanjirlariga bog'liq. Joriy ko'rsatkich 0.09 darajasida turibdi. Ushbu grafik organizmning himoya funksiyalarini yaxshilash va kasalliklarga qarshi kurashish uchun innovatsion dori vositalarini ishlab chiquvchi kompaniyaning narxlar dinamikasini aks ettiradi.

AGEN (Agenus) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

Agenus Inc. (AGEN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Agenus, Inc|AGEN - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Agenus, Inc|AGEN - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Agenus|AGEN - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi agenusbio.com|AGEN - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Agenus|AGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Agenus, Inc.|AGEN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Agenus, Inc|AGEN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Agenus|Shoshilinch likvidlik agenusbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
AGEN - Sof foyda
Kompaniyaning jamlanma tahlili:Agenus
Agenus Inc asosiy tovari

Operatsion biznes barqarorligi barqaror ijobiy pul oqimini yaratish qobiliyati bilan belgilanadi. Ushbu ko'rsatkich aktivlar sifatini baholash uchun fundamental tendentsiyani bozor shovqinlaridan ajratgan holda kunlik sof foydani o'lchaydi. Agenus (AGEN) uchun ushbu metrika bevosita saraton immunoterapiyasi uchun litsenziyalash kelishuvlarining muvaffaqiyatiga bog'liq. Ijobiy dinamika ishlanmalarning samaradorligi va pul oqimining kirib kelishini tasdiqlaydi. Kompaniyaning umumiy foydasini tahlil qilish kapitalning qadrsizlanish xatarlarini o'z vaqtida aniqlash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR: Sof foyda|Yillik sof foyda upstreambio.com UPB|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KalVista Corp - Kompaniya foydasi|Septerna Inc - Sof daromad|Sof foyda pieris.com PVLA|SVRA - Kompaniyaning sof foydasi|Sof moliyaviy natija Rigel Pharma RIGL|ANAB: Sof foyda|Astria Corp (ATXS) - Sof foyda|ENGN (enGene Holdings Inc.) - Sof foyda|RAPT - Yillik sof foyda|Sof foyda JBIO|ACRS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Kyverna KYTX|TLSA: Kompaniya foydasi|CABA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda VTYX|THTX: Sof foyda|Avalo Therapeutics, Inc. - Yakuniy foyda|ELDN (Eledon) - Sof foyda|Sof foyda Climb Bio, Inc|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR (atyrpharma.com) - Yakuniy foyda|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA - Sof daromad|Shattuck Therapeutics - Sof foyda|EQ - Sof foyda|CNTB (connectbiopharm.com) - Sof daromad|Immunic - Yakuniy foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Kompaniyaning sof foydasi X4 Pharma (XFOR)|Sof daromad adicetbio.com ACET|Kompaniyaning sof foydasi Celularity CELU|INMB - Sof daromad|BRNS: Sof daromad|KZR - Sof foyda|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Kompaniya foydasi AKTX|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Kompaniyaning sof daromadi Q32 Bio Corp QTTB|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|Sof foyda IBIO (iBio Corp)|Yillik sof foyda Carisma Therapeutics Inc|XTL Biopharmaceuticals - Sof foyda|Kompaniyaning sof daromadi Bolt Biotherapeutics|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Kompaniya foydasi APVO|Sof daromad AIM|Sof foyda Aditxt Corp|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof moliyaviy natija xortx.com|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|Indaptus - Sof foyda|Yillik sof foyda BiondVax Pharmaceuticals (SCNI)|CALI: Sof foyda|Kompaniyaning sof daromadi Affimed N.V. (AFMD)|Kompaniyaning sof foydasi Allakos Inc|Kompaniya foydasi HOOK (HOOKIPA)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|ITOS: Soliqdan keyingi foyda|Sof foyda OCEA (Ocean Biomedical, Inc.)|Yakuniy foyda TCBP|Third Harmonic Bio, Inc. - Sof foyda